FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 111 filers reported holding FIBROGEN INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $254,183 | -28.4% | 94,142 | +171.2% | 0.04% | -44.1% |
Q3 2021 | $355,000 | +49.8% | 34,710 | +502.3% | 0.07% | +126.7% |
Q3 2020 | $237,000 | -35.4% | 5,763 | -36.3% | 0.03% | -36.2% |
Q2 2020 | $367,000 | +282.3% | 9,044 | +302.3% | 0.05% | +193.8% |
Q4 2019 | $96,000 | – | 2,248 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 305,784 | $8,143,000 | 8.63% |
Vantage Consulting Group Inc | 605,713 | $16,130,000 | 2.81% |
GREAT POINT PARTNERS LLC | 500,000 | $13,315,000 | 2.79% |
HHLR ADVISORS, LTD. | 3,955,787 | $105,343,000 | 1.08% |
Intercontinental Wealth Advisors, LLC | 191,300 | $5,094,000 | 1.01% |
Ikarian Capital, LLC | 250,000 | $6,657,000 | 0.54% |
BHK Investment Advisors, LLC | 45,100 | $1,201,000 | 0.49% |
Ikarian Capital, LLC | 193,800 | $5,161,000 | 0.42% |
Omega Fund Management, LLC | 130,646 | $3,479,000 | 0.39% |
Rhenman & Partners Asset Management AB | 200,000 | $5,326,000 | 0.36% |